Human Anti-FLT4 scFv-Fc Chimera (VS-0425-FY54) (CAT#: VS-0425-FY54)

The anti-FLT4 scFv-Fc fusion protein is engineered to target Fms-like tyrosine kinase 4 (FLT4), also known as VEGFR-3, a key regulator of lymphangiogenesis. This protein combines a single-chain variable fragment (scFv) for high-specificity binding to FLT4 with an Fc domain to enhance stability and extend its circulating half-life. By inhibiting FLT4 signaling, it aims to modulate lymphatic vessel development and function, potentially impacting conditions like lymphedema and tumor metastasis. The Fc region allows for extended systemic exposure, increasing potential therapeutic efficacy. Current investigations are evaluating its ability to precisely modulate lymphangiogenesis for therapeutic purposes.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Specificity
  • Human FLT4
  • Species Reactivity
  • Human
  • Applications
  • ELISA

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Applications

  • Application Notes
  • The optimal dilution concentration is determined by the experiment.

Target

  • Alternative Names
  • Fms Related Tyrosine Kinase 4; Tyrosine-Protein Kinase Receptor FLT4; Fms-Like Tyrosine Kinase 4; EC 2.7.10.1; VEGFR-3; VEGFR3; FLT-4
  • Long Name
  • Fms Related Tyrosine Kinase 4
  • Sequence Similarities
  • Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
  • Cellular Localization
  • Cell membrane; Single-pass type I membrane protein; Cytoplasm; Nucleus
  • Post Translation Modifications
  • Autophosphorylated on tyrosine residues upon ligand binding.
    Glycosylation at Asn33, Asn104, Asn166, Asn251, Asn299, Asn411, Asn515, Asn527, Asn594, Asn683, Asn690, and Asn758
    Ubiquitination at Lys1253
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyGen 13 sites, 5 N-linked glycans (5 sites)
  • Function
  • Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFC and VEGFD, and plays an essential role in adult lymphangiogenesis and in the development of the vascular network and the cardiovascular system during embryonic development.
    Promotes proliferation, survival and migration of endothelial cells, and regulates angiogenic sprouting.
    Signaling by activated FLT4 leads to enhanced production of VEGFC, and to a lesser degree VEGFA, thereby creating a positive feedback loop that enhances FLT4 signaling.
    Modulates KDR signaling by forming heterodimers.
    The secreted isoform 3 may function as a decoy receptor for VEGFC and/or VEGFD and play an important role as a negative regulator of VEGFC-mediated lymphangiogenesis and angiogenesis.
    Binding of vascular growth factors to isoform 1 or isoform 2 leads to the activation of several signaling cascades; isoform 2 seems to be less efficient in signal transduction, because it has a truncated C-terminus and therefore lacks several phosphorylation sites.
    Mediates activation of the MAPK1/ERK2, MAPK3/ERK1 signaling pathway, of MAPK8 and the JUN signaling pathway, and of the AKT1 signaling pathway.
    Phosphorylates SHC1.
    Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase.
    Promotes phosphorylation of MAPK8 at 'Thr-183' and 'Tyr-185', and of AKT1 at 'Ser-473'.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "FLT4"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products Mouse Antibody Products IgG Antibody Products Blocking Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products Extracellular Vesicle (EV) Antibody Products
CAT Product Name Application Type
TAB-292CL Human Anti-FLT4 Recombinant Antibody (TAB-292CL) ELISA Human IgG1

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0425-FY54. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare